These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7904388)

  • 1. The therapeutic role of sulfated polysaccharides in the urinary bladder.
    Parsons CL
    Urol Clin North Am; 1994 Feb; 21(1):93-100. PubMed ID: 7904388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bladder surface glycosaminoglycan: efficient mechanism of environmental adaptation.
    Parsons CL
    Urology; 1986 Feb; 27(2 Suppl):9-14. PubMed ID: 3946050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis.
    Parsons CL
    Urology; 2007 Apr; 69(4 Suppl):9-16. PubMed ID: 17462486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation of the nature of bladder mucosal glycoconjugates and their role in interstitial cystitis.
    Bhavanandan VP; Erickson DR
    Indian J Biochem Biophys; 1997; 34(1-2):205-11. PubMed ID: 9343952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Culture of bladder epithelium from cystoscopic biopsies of patients with interstitial cystitis.
    Trifillis AL; Cui X; Jacobs S; Warren JW
    J Urol; 1995 Jan; 153(1):243-8. PubMed ID: 7966781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder botulinum toxin A injection can benefit patients with radiation and chemical cystitis.
    Chuang YC; Kim DK; Chiang PH; Chancellor MB
    BJU Int; 2008 Sep; 102(6):704-6. PubMed ID: 18485037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of interstitial and radiogenic cystitis with D-glucosamine].
    Strohmaier WL; Quack M; Wilbert DM; Bichler KH
    Helv Chir Acta; 1989 Aug; 56(3):323-5. PubMed ID: 2807960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model for the function of glycosaminoglycans in the urinary tract.
    Parsons CL
    World J Urol; 1994; 12(1):38-42. PubMed ID: 8012414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of patients with interstitial cystitis, with special reference to intravesical DMSO.
    Stewart BH; Branson AC; Hewitt CB; Kiser WS; Straffon RA
    Trans Am Assoc Genitourin Surg; 1971; 63():69-74. PubMed ID: 5137793
    [No Abstract]   [Full Text] [Related]  

  • 10. A new direct test of bladder permeability.
    Erickson DR; Herb N; Ordille S; Harmon N; Bhavanandan VP
    J Urol; 2000 Aug; 164(2):419-22. PubMed ID: 10893600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of exogenous glycosaminoglycans on the histological structure of the rat bladder in experimental cystitis.
    Sobolev VE
    Bull Exp Biol Med; 2012 Nov; 154(1):108-11. PubMed ID: 23330103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of anti-microbial peptide LL-37-induced apoptosis and ATP release in the urinary bladder by a modified glycosaminoglycan.
    Lee WY; Savage JR; Zhang J; Jia W; Oottamasathien S; Prestwich GD
    PLoS One; 2013; 8(10):e77854. PubMed ID: 24204996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative efficacy of various exogenous glycosaminoglycans in providing a bladder surface permeability barrier.
    Nickel JC; Downey J; Morales A; Emerson L; Clark J
    J Urol; 1998 Aug; 160(2):612-4. PubMed ID: 9679938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder stretch alters urinary heparin-binding epidermal growth factor and antiproliferative factor in patients with interstitial cystitis.
    Chai TC; Zhang CO; Shoenfelt JL; Johnson HW; Warren JW; Keay S
    J Urol; 2000 May; 163(5):1440-4. PubMed ID: 10751853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the bladder surface in interstitial cystitis/painful bladder syndrome.
    Teichman JM; Moldwin R
    Can J Urol; 2007 Aug; 14(4):3599-607. PubMed ID: 17784979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of interstitial cystitis on drug absorption from urinary bladder.
    Gao X; Buffington CA; Au JL
    J Pharmacol Exp Ther; 1994 Nov; 271(2):818-23. PubMed ID: 7965801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of sodium urate crystal adherence to bladder surface by polysaccharide.
    Parsons CL; Danielson B; Feldstrom B
    J Urol; 1985 Sep; 134(3):614-6. PubMed ID: 2411955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of pituitary adenylate cyclase-activating polypeptide in urinary bladder pathways after chronic cystitis.
    Vizzard MA
    J Comp Neurol; 2000 May; 420(3):335-48. PubMed ID: 10754506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the mast cell in interstitial cystitis.
    Sant GR; Theoharides TC
    Urol Clin North Am; 1994 Feb; 21(1):41-53. PubMed ID: 8284844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary chondroitin sulfates, heparan sulfate and total sulfated glycosaminoglycans in interstitial cystitis.
    Erickson DR; Ordille S; Martin A; Bhavanandan VP
    J Urol; 1997 Jan; 157(1):61-4. PubMed ID: 8976216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.